Plné znění - 47/2014 Sb. m. s.

Sdělení o přijetí nového znění Přílohy I (Seznam zakázaných látek a metod - Mezinárodní standard) Mezinárodní úmluvy proti dopingu ve sportu

47/2014 Sb. m. s.

Sdělení

INFORMACE

47

XXXXXXX

Xxxxxxxxxxxx xxxxxxxxxxxx xxxx,

xxxxxx xx mění a xxxxxxxx xxxxxxx Ministerstva xxxxxxxxxxxx věcí x. 58/2007 Xx. x. x. a x. 46/2008 Sb. x. x. x xxxxxxxxx xxxxxxx Ministerstva xxxxxxxxxxxx xxxx x. 98/2013 Xx. x. x. x Xxxxxxxxxxx úmluvě xxxxx dopingu xx xxxxxx

Xxxxxxxxxxxx xxxxxxxxxxxx xxxx xxxxxxx, xx xxx 11. listopadu 2013 xxxx xxxxxxxxx ředitelkou XXXXXX oznámeno xxxxxxxxx xxxxxx xxxxx Xxxxxxx X - Xxxxxxx xxxxxxxxxx xxxxx a xxxxx - Mezinárodní xxxxxxxx Xxxxxxxxxxx úmluvy xxxxx xxxxxxx xx xxxxxx.¹⁾

X xxxxx xxxxxx Xxxxxxx X xxxxxxxx xxxxxxx Xxxxxxxxx Xxxxx xxxxxxxxx a xxxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxx x xxxxxxx xxxxx Xxxxxxx X Xxxxxx xxxxxxxxxx.

Xxxx xxxxx Přílohy X xxxxxxxxx x xxxxxxxx x xxxxxxx x článkem 34 xxxx. 3 Úmluvy xxx 1. xxxxx 2014 a tímto xxxx vstoupilo x xxxxxxxx x xxx Xxxxxx republiku. Dnem xxxxxx nového xxxxx Xxxxxxx X x xxxxxxxx přestalo platit xxxxx Xxxxxxx X Xxxxxxxxxxx úmluvy xxxxx xxxxxxx xx xxxxxx xxxxxx xx 1. xxxxx 2013 x xxxxxxxxx xxx č. 98/2013 Sb. m. s.

Xxxxxxxx xxxxx Xxxxxxx X x xxxx xxxxxxx xx xxxxxxx xxxxxx xx vyhlašují xxxxxxxx.

¹⁾ Xxxxxxxxxxx xxxxxx proti xxxxxxx xx sportu xxxxxxx xxx 19. xxxxx 2005 x Xxxxxx byla vyhlášena xxx č. 58/2007 Sb. m. s. x č. 46/2008 Sb. m. s.

XXXXXXXXXXX ÚMLUVA XXXXX XXXXXXX XX XXXXXX
Xxxxxxx X - Xxxxxx xxxxxxxxxx xxxxx a xxxxx - Xxxxxxxxxxx xxxxxxxx
Xxxxx, 1. xxxxx 2014

XXXXXX XXXXXXXXXX XXXXX X XXXXX DOPINGU XXX ROK 2014

SVĚTOVÝ XXXXXXXXXXXXX XXXXX

Xxxxxx xx 1. xxxxx 2014

Xxxxx xxxxxx 4.2.2 Světového xxxxxxxxxxxxxxx kodexu xxxxxxx Xxxxxxxx xxxxx budou xxxxxxxxxx xx "Xxxxxxxxxx xxxxx" kromě xxxxx xx xxxxxx S1, X2, X4.4, X4.5 x S6(a) x Xxxxxxxxxx xxxxx X1, X2 x X3.

XXXXX X XXXXXX XXXXXXXX XXXXX (XXX XXXXXXX X XXXX SOUTĚŽ)

ZAKÁZANÉ XXXXX

X0. XXXXXXXXXXX XXXXX

Xxxxxxxxx xxxxxxxxxxxxx xxxxx, xxxxx xxxx xxxxxxxx x následujících xxxxxxx Seznamu x xxxx xxxxxxxx xxxxxxxxx xxx xxxxxxx xxxxxxxxxxxx xxxxxxx jakýmkoliv vládním xxxxxxxxxxxxx xxxxxxxxxx úřadem (xxxx. xxxxxx x xxxxxxxxxxxx xxxx klinickém xxxxxx výzkumu nebo xx xxxxxxxx xxxxxxxxxx, xxxxxxxxxx xxxxx, látky xxxxxxxxx xxxxx xxx xxxxxxxxxxx xxxxxxx), xx xxxxxxxx xxxxx.

X1. ANABOLICKÉ XXXXX

Xxxxxxxxxx xxxxx xxxx xxxxxxxx.

1. XXXXXXXXXX XXXXXXXXXX XXXXXXXX (XXX):

(x) Xxxxxxxx* XXX, xxxxxxxxxx:

1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3x,17β-xxxx); 1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3,17-xxxx); xxxxxxxxx (xxxx-4-xx-3β,17β-xxxx); xxxxxxxxxx; boldenon; xxxxxxx (xxxxxxxx-1,4-xxxx-3,17-xxxx); xxxxxxx ([1,2]xxxxxx[4',5':2,3]xxxxxx-4-xx-20-xx-17α-xx); xxxxxxxxxxxxxxxxxxxxxxxxxxxxx (4-chloro-17β-hydroxy-17α-methylandrosta-1,4-dien-3-on); xxxxxxxxxxxxxxxxxxxxxxx (17α-xxxxxx-5α-xxxxxxx-2-xx-17β-xx); xxxxxxxxxxx; xxxxxxxxxxxxx (19-xxx-xxxxxx-4-xx-17α-xx); fluoxymesteron; xxxxxxxxxx; furazabol (17α-methyl[1,2,5]oxadiazolo[3',4':2,3]-5α-androstan-17β-ol); xxxxxxxxx; 4-xxxxxxxxxxxxxxxxxx (4,17β-xxxxxxxxxxxxxxxx-4-xx-3-xx); xxxxxxxxxx; klostebol; xxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxx; xxxxxxxxxxx; xxxxxxxxxx (17β-xxxxxxx-2α,17α-xxxxxxxx-5α-xxxxxxxxx-3-xx); methyldienolon (17β-xxxxxxx-17α-xxxxxxxxxxx-4,9-xxxx-3-xx); xxxxxx-1-xxxxxxxxxxx (17β-hydroxy-17α-methyl-5α-androst-1-en-3-on); xxxxxxxxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4-xx-3-xx); methyltestosteron; metribolon (xxxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxxx-4,9,11-xxxxx-3-xx); xxxxxxxxx; xxxxxxxxx; 19-xxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx); xxxxxxxxxx; norethandrolon; xxxxxxxxxxxx; xxxxxxxx; xxxxxxxxxx; oxymesteron; xxxxxxxxxx; xxxxxxxxxxx (17β-[(tetrahydropyran-2-yl)oxy]-1'H-pyrazolo[3,4,:2,3]-5α-androstane); xxxxxxxxx; stanozolol; xxxxxxxxx; 1-xxxxxxxxxxx (17β-hydroxy-5α-androst-1-en-3-on); tetrahydrogestrinon (17-xxxxxxx-18α-xxxx-19-xxx-17α-xxxxxx-4,9,11-xxxxx-3-xx); xxxxxxxxx (17β-hyroxyestr-4,9,11-trien-3-on) x xxxxx látky x podobnou xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx účinky.

(b) Endogenní** XXX, xxxxx xxxx xxxxxx exogenně:

Androstendiol (androst-5-en-3β,17β-diol), xxxxxxxxxxxxx (xxxxxxx-4-xx-3,17-xxxx), xxxxxxxxxxxxxxxxxx, xxxxxxxxx (xxxxxxxxxxxxxxxxxxxxx, DHEA), 3β-xxxxxxxxxxxxx-5-xx-17-xx), xxxxxxxxxxx a xxxxxx metabolity a xxxxxxx, xxx xx x xxxxxxxx xxxxx xx ně:

5α-androstan-3α,17α-diol	5-androstendion (xxxxxxx-5-xx-3,17-xxxx)
5α-xxxxxxxxx-3α,17β-xxxx	xxx-xxxxxxxxxxxxxxxxxx
5α-xxxxxxxxx-3β,17α-xxxx	xxxxxxxxxxxxxx
5α-xxxxxxxxx-3β,17β-xxxx	xxxxxxxxxxxxxx
xxxxxxx-4-xx-3α,17α-xxxx	3α-xxxxxxx-5αxxxxxxxxx-17-xx
xxxxxxx-4-xx-3α,17β-xxxx	3β-xxxxxxx-5αxxxxxxxxx-17-xx
xxxxxxx-5-xx-3β,17α-xxxx	7α-xxxxxxx-XXXX
xxxxxxx-5-xx-3α,17α-xxxx	7β-xxxxxxx-XXXX
xxxxxxx-5-xx-3α,17β-xxxX	7-xxxx-XXXX
xxxxxxx-5-xx-3β,17α-xxxx	19-xxxxxxxxxxxxxx
4-xxxxxxxxxxxxx (xxxxxxx-4-xx-3β,17β-xxxx)	19-xxxxxxxxxxxxxxxxx

Xxx účely xxxxxxx xxxx xxxxx:

* "exogenní" xx xxxxxxxx x xxxxx, xxxxxx tělo xxxxxxxx přirozeně xxxxxxxxxxx.

** "xxxxxxxxx " se xxxxxxxx x xxxxx, xxxxxx xxxx normálně xxxxxxxxx xxxxxxxxx.

2. Ostatní xxxxxxxxxx látky, xxxxxxxxxx:

Xxxxxxxxxxx, xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxx (SARM), tibolon, xxxxxxx, xxxxxxxxxx, xxx xx x xxxxxxxx xxxxx xx xx.

X2. XXXXXXXXX XXXXXXX, RŮSTOVÉ XXXXXXX X XXXXXXXX XXXXX

Xxxxxxxxxxx látky a xxxxx látky x xxxxxxxx chemickou xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx xxxx xxxxxxxx:

1. Xxxxx xxxxxxxxxxx xxxxxxxxxxx (xxxx. xxxxxxxxxxxx (EPO), xxxxxxxxxxx (dEPO), xxxxxxxxxxxxx xxxxxxx xxxxxxxxxxxxxx xxxxxxx (XXX), xxxxxxxxxxxxxxxxxxxxxxxx-xxxxxxx xxxx (XXXX), xxxxxxxxxxx /Xxxxxxxx/);

2. Xxxxxxxxxxxxxxxxxx (XX) x Xxxxxxxxxxxx hormon (LH) x jejich xxxxxxxxxx xxxxxxx x mužů;

3. Xxxxxxxxxxxxxx x jejich xxxxxxxxxx xxxxxxx;

4. Xxxxxxx xxxxxx (XX) x xxxx xxxxxxxxxx faktory x insulinu xxxxxxx xxxxxxx faktor-1 (XXX-1).

Xxxxx xxxx xxxx xxxxxxxx xxxxxxxxxxx xxxxxxx xxxxxxx:

Xxxxxxxxxxxxx xxxxxxx xxxxxxx (FGFs), xxxxxxxxxxxx xxxxxxx faktor (XXX), mechanické růstové xxxxxxx (XXX), xxxxxxx xxxxxx odvozený z xxxxxxxx xxxxxxxx (XXXX) x xxxxxxxxxx-xxxxxxxxxxxx xxxxxxx xxxxxx (XXXX), xxxxxx xxxx xxxxxxxxx xxxx xxxxxxx xxxxxxx ovlivňující xxxxxxx nebo xxxxxxxxx xxxxxxxx svalů, xxxxx x vaziva, xxxxxx xxxxxxxx, xxxxxxx xxxxxxx, xxxxxxxxxxxxx kapacitu xxxx xxxxxxxxxxx xxxx xxxxxxxxx xxxxxx;

x další xxxxx x xxxxxxxx chemickou xxxxxxxxxx nebo xxxxxxxxx xxxxxxxxxxxx účinky.

S3. XXXX2- XXXXXXXX

Xxxxxxx beta-2 agonisté, xxxxxx xxxxx případných xxxxxxxxx xxxxxxx (např. x- x x-), xxxx xxxxxxxx xxxxx xxxxxxxxxxx xxxxxxxxxxx (xxxxxxxxx 1600 mikrogramů xx 24 xxxxx), xxxxxxxxxxxx xxxxxxxxxxx (xxxxxxxxx xxxxxx xxxxx 54 xxxxxxxxxx xx 24 xxxxx) x salmeterolu, pokud xxxx xxxxxx v xxxxxxxx x xxxxxxx x xxxxxxxxxxx xxxxxxxx xxxxxxx xxxxxxx.

Xxxxxxxxxx salbutamolu x moči x xxxxxxxxxxx vyšší než 1000 ng/ml x xxxxxxxxxx formoterolu x xxxx v koncentraci xxxxx než 40 xx/xx nebude xxxxxxxxxx xx xxxxxxxxx xxxxxxxxxxxx xxxxxxx, ale xxxx xxxxxxxxxx xx xxxxxxxxx xxxxxxxxxxx xxxxx, xxxxx xxxxxxxxx xxxxxxxxx kontrolovanou xxxxxxxxxxxxxxxxx xxxxxx, že xxxxxxxxxx xxxxxxxx xxx xxxxxxxx xxxxxxxx xxxxxxxxxxxx xxxxxxxxx dávky nižší xxx xxxx uvedené xxxxxxx.

X4. XXXXXXXXX X XXXXXXXXXXX XXXXXXXXXX

Xxxxxxxx xx xxxxxxxxxxx:

1. Xxxxxxxxxx xxxxxxxx, xxxxxxxxxx:

Xxxxxxxxxxxxxxxx, xxxxxxxxxx, xxxxxxxx-1,4,6-xxxxx-3-17-xxxx (xxxxxxxxxxxxxxxxx), 4-xxxxxxxxx-3,6,17-xxxxx (6-xxx), xxxxxxxxx, xxxxxxxxx, letrozol, xxxxxxxxxxx, xxx xx x omezením xxxxx xx xx.

2. Xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxx (XXXX), xxxxxxxxxx:

Xxxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxx ne x omezením xxxxx xx xx.

3. Xxxxxxx xxxxxxxxxxxxxx látky xxxxxxxxxx:

Xxxxxxxxxx, xxxxxxxxxxx, xxxxxxxx, xxx xx s omezením xxxxx xx ně.

4. Xxxxx xxxxxxxxxxxx funkce xxxxxxxxxx xxxxxx inhibitorů xxxxxxxxxx, ale xx x xxxxxxxx xxxxx xx ně.

5. Xxxxxxxxxxx xxxxxxxxxx:

x) Insuliny;

b) Receptor xxxxx xxxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxxx /Xxxxxxxxxx Xxxxxxxxxxxx Xxxxxxxxx Xxxxxxxx δ (XXXXδ) xxxxxxxx/ (xxxx. XX 1516) x Xxxxxxxx xxxxxxxxxxxxxxx xxx xxxxxxxxxx XXX v xxxxxxxxxxx x XXXX xxxxx /XXXXδ-XXX-xxxxxxxxx xxxxxxx xxxxxx (XXXX) xxxx xxxxxxxx/ (např. XXXXX)

X5. XXXXXXXXX X OSTATNÍ XXXXXXXXX XXXXX

Xxxxxxxxx xxxxx xxxx xxxxxxxx. Zahrnují:

Diuretika, xxxxxxxxxxxx, xxxxxxxxxxxxxxx (xxxx. xxxxxxxx, nitrožilní podání xxxxxxxx, xxxxxxxx, xxxxxxxxxxxxxxxxxx x mannitolu), xxxxxxxxxx x další látky x xxxxxxxxx xxxxxxxxxxxx xxxxxx. Xxxxxxx xxxxxx xxxxxxxxxxxx xxx zubní xxxxxxxx xxxx xxxxxxxx.

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxxxxx, amilorid, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxx, xxxxxxxx, xxxxxxxx xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxx (xxxx. xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx), triamteren, vaptany (xxxx. xxxxxxxxx) x xxxxx xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx (kromě xxxxxxxxxxxx, xxxxxxxxx a xxxxxxxxx xxxxxx xxxxxxxxxxx x xxxxxxxxxxxx, xxxxx nejsou xxxxxxxx).

Xxx xxxxxxx (Při Xxxxxxx, případně Mimo Xxxxxx) xxxxxxxxxxx množství xxxxx se xxxxxxxxxx xxxxxxxx xxxxxxx (tj. xxxxxxxxxx, salbutamol, xxxxx, xxxxxxx, xxxxxxxxxxxx x xxxxxxxxxxxxx) xx xxxxxxx x diuretikem xxxx xxxxx xxxxxxxxx látkou xx xxxxxxxxxx xxxxxxx xxxxxxxxxx Xxxxxxxxxxxx xxxxxxx xx xxxx xxxxx xxxxx x xx, xxxxx xxx byla xxxxxxx na xxxxxxxxxx xxxx xxxxx maskovací xxxxx.

XXXXXXXX XXXXXX

X1. MANIPULACE X KRVÍ A XXXXXXXX KOMPONENTAMI

Zakázané xx xxxxxxxxxxx:

1. Xxxxxx xxxx xxxxxxxxxxxxx xxxxxxxxxxx množství xxxxxxxxx, xxxxxxxx (homologní) xxxx heterologní xxxx xxxx červených xxxxxxx x xxx xxxxxxxxx xxxxxxxx xxxxxxxxxxx xxxxxx xx xxxxxxxxx xxxxxxx.

2. Xxxxx xxxxxxxxx xxxxxxxx, xxxxxxx nebo xxxxxxx xxxxxxx, xxxxxxxxxx modifikované xxxxxxxxxxxxx produkty (např. xxxxxx xxxxxxxx xxxxxxxx xx xxxxxxxxxxx, xxxxxxxxxxxxxxxxxx xxxxxxxxxxx), perfluorochemikálie a xxxxxxxxxxx (XXX13), xxx xx s xxxxxxxx xxxxx xx ně. Xxxxxxxxxxxx kyslíkem zakázána xxxx.

3. Xxxxxxxxx forma xxxxxxxxxxxxxxx xxxxxxxxxx x xxxx xxxx s xxxxxxxx komponentami xxxxxxxxxxx xxxx xxxxxxxxxx způsoby.

M2. XXXXXXXX X FYZIKÁLNÍ XXXXXXXXXX

Xxxxxxxx xx následující:

1. Xxxxxxxxx, nebo pokus x xxxxxx, xx xxxxxx xxxxxxx xxxxxxxxx x platnost Xxxxxx xxxxxxxxxx xxx Dopingové xxxxxxxx. Xx xxxxxxxx xxxxxx x/xxxx xxxxxx (xxxx. xxxxxxxxxx) moči, xxx xx x xxxxxxxx pouze na xx.

2. Xxxxxxxxxx xxxxxx x/xxxx injekce více xxx 50 ml xx 6 xxxxx xxxxx xxxxxx xxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxxx xxxxxxx xxxx xxxxxxxxxx xxxxxxxxxxxxx xxxxx.

X3. XXXXXX XXXXXX

X xxxxxx xxxxxxxxxx ke zvýšení xxxxxxxxxxx xxxxxx je xxxxxxxx xxxxxxxxxxx:

1. Transfer xxxxxxxx nukleových xxxxxxx xxxx jejich analogů;

2. Xxxxxxx normálních xxxx xxxxxxxxx xxxxxxxxxxxxxx xxxxx.

XXXXX X METODY ZAKÁZANÉ XXX XXXXXXX

Xxxxx xxxxxxxxx X0 xx X5 x X1 xx X3 uvedených xxxx xxxx Xxx Soutěži xxxxxxxx x následující xxxxxxx:

XXXXXXXX XXXXX

X6. XXXXXXXXXXX

Xxxxxxx xxxxxxxxxxx xxxxxx xxxxx xxxxxx xxxxxxxxxx xxxxxxxxx xxxxxxx (xxxx. x- x x-) jsou xxxxxxxx, s xxxxxxxx xxxxxxxx xxxxxxxxx x xxxxxxx xxxxxx xxxxxxxx xxxxxxx a xxxxxxxxxxx xxxxxxxxxx xx Xxxxxxxxxxxxxx xxxxxxxx xxx rok 2014*.

Xxxxxxxxxxx xxxxxxxx:

(x) Xxxxxxxxxxxx xxxxxxxxxxx:

Xxxxxxxxx, amfepramon, amfetamin, xxxxxxxxxxx, amifenazol, xxxxxxxxxx, xxxxxxxxxxxxxxx, bromantan, xxxxxxxxxxxxx, xxxxxxxxx, fenfluramin, xxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxx, fentermin, xxxxxxxxxxxx /4-fenylpiracetam (xxxxxxxx)/, xxxxxxxxxx, klobenzorex, kokain, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, metamfetamin (x-), xxxxxxxx, xxxxxxxxx, norfenfluramin, x-xxxxxxxxxxxxxxx, prenylamin, prolintan.

Stimulancium, xxxxx xxxx xxxxxxxx xxxxxxx x xxxxx xxxxxxxx, je Xxxxxxxxxxx xxxxxx.

(x) Specifická xxxxxxxxxxx (xxxxxxxx):

Xxxxxxxxx (xxxxxxxxx)****, benzfetamin, xxxxxxxxxxxxxxxxx, xxxxxxx***, xxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxx, famprofazon, xxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxxx, hydroxyamfetamin (xxxxxxxxxxxxxxxxxx), xxxxxxxxxxxx, xxxxx**, katinon x xxxx xxxxxxx (xxxx. mefedron, methedron, xxxx-xxxxxxxxxxxxxxxxxxxxx), levmetamfetamin, meklofenoxát, xxxxxxxxxxxx***, metylendioxymetamfetamin, xxxxxxxxxxxx, xxxxxxxxxxxxxx (dimetylpentylamin), níketamid, xxxxxxxxxxx, oktopamin, xxxxxxxxx (xxxxxxxxxxxxx), xxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxxxxxx*****, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxx, tenamfetamin (xxxxxxxxxxxxxxxxxxxxx), xxxxxxxxxxxx, xxxxxxxxxxxxx x další xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx nebo xxxxxxxxx xxxxxxxxxxxx účinky.

* Následující xxxxx zahrnuté do Xxxxxxxxxxxxxx xxxxxxxx 2014 (xxxxxxxxx, xxxxxxxxxx, fenylpropanolamin, xxxxxx, xxxxxxx, pipradrol, xxxxxxxx) xxxxxx xxxxxxxxxx xx Xxxxxxxx xxxxx.

** Xxxxx xx xxxxxxxx xxxxx xxx xxxxxxxxxxx xxxxx xxx 5 xxxxxxxxxx x 1 xx xxxx.

*** Efedrin x xxxxxxxxxxxxx xxxx xxxxxxxx xxx xxxxxxxxxxx xxxxx než 10 xxxxxxxxxx x 1 xx xxxx.

**** Lokální xxxxxx adrenalinu (xxxxxxxxxx) (xxxx. xxxxx, xxxx xxxxxxxx) nebo jeho xxxxxx xxxxxxxx x xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxx.

***** Pseudoefedrin xx xxxxxxx, pokud xxxx xxxxxxxxxxx v xxxx xx xxxxx než 150 xxxxxxxxxx na xxxxxxxx.

X7. XXXXXXXXX

Xxxxxxxx je xxxxxxxxxxx:

Xxxxxxxxxxx, xxxxxxxxxxxxx, diamorfin(heroin), xxxxxxxx x jeho xxxxxxxx, xxxxxxxxxxx, metadon, xxxxxx, oxykodon, xxxxxxxxx, xxxxxxxxxx, xxxxxxx.

X8. KANABINOIDY

Přírodní (xxxx. hašiš, konopí x marihuana) xxxx xxxxxxxxxx xxxxx9-xxxxxxxxxxxxxxxxxxx (XXX) x xxxxxxxxxxxxxx (např. "Xxxxx", XXX018, XXX073 x XX-210) xxxx xxxxxxxx.

X9. GLUKOKORTIKOSTEROIDY

Všechny glukokortikosteroidy xxxxxxxx xxxxxx, xxxxxxxx, xxxxxxxxxx xxxx xxxxxxxxxxxxx xxxxxxxx xxxx xxxxxxxx.

XXXXX XXXXXXXX X XXXXXXXX XXXXXXXX

X1. ALKOHOL

Alkohol (etanol) xx zakázaný xxxxx Xxx Soutěži x xxxxxxxxxxxxx xxxxxxxx. Xxxxxxx xx xxxx provádět xxxxxxxx zkouškou x/xxxx xxxxxxxx xxxx. Prahová xxxxxxx pro porušení xxxxxxxxxxx xxxxxxxx xx xxxxxxxxxxxx koncentrací xxxxxxxx x xxxx 0.10 x/x.

• Xxxxxxxxxxxx xxxxx (XXX)

• Xxxxxx (XXX)

• Xxxxxxx xxxxxx a xxxxxxxxxxxx (FAI)

• Xxxxxxxxxxx (XX)

• Xxxxxxxxxxx sport (XXX)

• Vodní xxxxxxxxxx (XXX)

X2. XXXX-XXXXXXXXX

Xxxxx není xxxxx určeno, xxxx-xxxxxxxxx xxxx zakázány pouze Xxx Xxxxxxx x xxxxxxxxxxxxx xxxxxxxx.

• Xxxxxxxxxxxx xxxxx (FIA)

• Xxxxxxxx (xxxxxxx xxxxxxxxxx) (WCBS)

• Xxxx (XXX)

• Lukostřelba (XX) (xxxxxxxx xxxx Xxxx xxxxxx)

• Lyžování (XXX) - xxxxx xx lyžích a xxxxxxxxxxx xxxxxxxx-xxxxx a X-xxxxx, a xxxxxxxxx X-xxxxx x "xxx xxx"

• Xxxxxxx (XXXX, XXX) (zakázané také Xxxx xxxxxx)

• Xxxxx (XXX)

Xxxx-xxxxxxxxx zahrnují xxxxxxxxxxx xxxxx:

Xxxxxxxxxx, alprenolol, xxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxx, xxxxxxxxxx, esmolol, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxx, xxxxxxx, xxxxxxxxxx, pindolol, xxxxxxxxxxx, xxxxxxx, xxxxxxx, ale xx s omezením xxxxx xx xx.

Xxxxxxxxx

Xxxxxx xxxxxxx č. 47/2014 Xx. m. x. xxxxx xxxxxxxxx xxxx 20.9.2014.

Xxxxxx xxxxxxx x. 47/2014 Sb. x. x. byl xxxxxx xxxxxxx xxxxxxxxx č. 19/2017 Sb. m. s. s xxxxxxxxx xx 6.4.2017.

Znění xxxxxxxxxxxx xxxxxxxx norem xxxxxx xxxxxxxx předpisů v xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx jich xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.